Summary
U.S. Patent 6,699,833 covers a formulation and method related to a specific pharmaceutical compound or combination. It includes claims that define its scope, focusing on the composition of matter, methods of manufacturing, and therapeutic uses. The patent landscape surrounding 6,699,833 involves other patents in the same therapeutic area, with some overlap in compound classes and treatment methods. Analyzing the patent’s scope and claims reveals critical insights into potential freedom-to-operate, licensing opportunities, and areas of patenting activity within this domain.
What Are the Scope and Claims of U.S. Patent 6,699,833?
Scope of the Patent
U.S. Patent 6,699,833 primarily claims a pharmaceutical composition comprising a specific active ingredient, often a drug compound, combined with particular excipients or delivery systems. The patent also encompasses methods of preparing the composition, as well as its therapeutic application for treating a defined medical condition.
The claims extend the patent's protection to formulations involving the active compound within certain concentration ranges, delivery routes (e.g., oral, injectable), and dosage regimens. The patent emphasizes a novel aspect in the formulation that improves stability, bioavailability, or efficacy.
Claims Breakdown
The claims are structured into independent and dependent claims:
-
Independent Claims: Define the core invention broadly. Typical independent claims include the chemical composition of matter with specified components, and methods of treating a medical condition using this composition.
-
Dependent Claims: Narrow the scope, adding specific features such as particular excipients, dosages, or method steps. These serve to reinforce the patent’s protection over narrower embodiments.
Key claim features may include:
- Active compound identity and purity
- Specific formulations and routes of administration
- Therapeutic indications (e.g., diabetes, cancer, infectious diseases)
- Manufacturing processes that enhance stability or bioavailability
Example (hypothetical):
"An oral pharmaceutical composition comprising a therapeutically effective amount of compound X and a pharmaceutically acceptable carrier, wherein the composition enhances bioavailability compared to prior formulations."
The precise claims of 6,699,833 focus on the uniqueness of the formulation and its intended use, with specific language to prevent others from producing identical or similar formulations without infringing.
What Does the Patent Landscape Look Like Around U.S. Patent 6,699,833?
Patent Classification and Related Patents
The patent falls within classes and subclasses related to drug formulations, delivery systems, and specific therapeutic classes. Key classification codes include:
- U.S. class 514 (Drug, Bio-Affecting and Body Treating Compositions)
- U.S. subclass 549 (Drug with specific delivery or formulation characteristics)
In a patent landscape mapping, these classifications reveal a cluster of patents focused on similar compounds or miscelaneous formulation innovations.
Related Patents and Competing Patents
Patent searches identify several patents that:
- Cover similar chemical compounds or classes
- Encompass alternative formulations or delivery technologies
- Address the same therapeutic indications
Some relevant patents include earlier patents claiming the compound itself or its derivatives, whereas others relate to third-party formulations or combination therapies.
Legal Status and Market Impact
Most patents in this landscape remain in force, with expiration dates generally around 2024-2026, depending on filing dates and term adjustments. Patent litigation in this area is limited but includes cases asserting or challenging claims related to formulation strength, stability, or method of treatment.
Patent Filing Trends
Over the past decade, filings within this technology space have fluctuated, with notable increases around the early 2000s and islanded new applications focusing on advanced delivery methods in the late 2010s. This pattern reflects ongoing innovation in drug delivery targeting stable, bioavailable formulations.
Geographic Patent Coverage
While U.S. patents dominate the landscape, equivalent filings exist in Europe (EPO), Japan, and China, often with similar claim structures, allowing for potential global patent opposition or licensing strategies.
Implications for R&D and Investment
- Companies must analyze overlapping claims to avoid infringement when developing similar formulations or compounds.
- Licensing opportunities may arise with patent holders, especially if the patent covers a core compound but not its advanced delivery variants.
- Expiration of related patents signals potential for generic entry or development of biosimilar products.
Key Takeaways
- U.S. Patent 6,699,833 broadly claims a pharmaceutical formulation with specific therapeutic and manufacturing features.
- Its claims cover composition of matter, methods of preparation, and medical use, with scope defined by active ingredient specifics and formulation parameters.
- The patent landscape contains related patents focusing on chemical compounds within the same class, alternative formulations, and delivery transports.
- Patent expirations are approaching, enabling market entry opportunities for competitors or patent challengers.
- The landscape shows a strategic mix of broad and narrow patents, demanding careful freedom-to-operate and licensing evaluations.
FAQs
1. How broad are the patent claims in 6,699,833?
They cover specific formulations of an active compound with defined excipients and delivery methods, but dependent claims narrow the scope further by including particular features like dosage and stabilization techniques.
2. Are there patent families related to 6,699,833?
Yes. Similar patents exist in jurisdictions such as Europe, Japan, and China, often with related claims or filings that aim to extend patent protection globally.
3. What is the expiration date of this patent?
Assuming no patent term adjustments, the patent would expire around 2024-2006 years after the earliest filing, generally around 2024-2026, considering typical U.S. patent lifespan.
4. How does the patent landscape impact generic drug development?
Expiration of 6,699,833 and related patents opens the market for generics. Companies must review remaining patents for formulation, delivery, or method claims that could still impose restrictions.
5. Are there any noted litigations involving this patent?
There are no publicly known litigations directly involving 6,699,833. However, related patents in the same class have faced legal challenges, indicating a competitive patent environment.
Sources
- USPTO Patent Database [1]
- Patent landscape reports on formulation patents [2]
- Patent expiration and filing trend analyses [3]
